(MAH Pilot Project)
(including HK, Macau and Taiwan)
Taiwan Phase 1
(except North America)
Squamous cell esophageal cancer
Mucositis caused by radiation or high dose chemotherapy
CANbridge launched rare disease business platform to commercialize Western rare disease therapies via an innovative business approach in China.
Chronic diseases with official rare disease designations.
Serious & debilitating diseases excluding cancers.
Genetic diseases with unique genetic profile/prevalence in China.
Significant unmet medical needs in China.